Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APPLIED UV, INC.

(AUVI)
  Report
Delayed Nasdaq  -  04:00 2022-09-23 pm EDT
1.420 USD   -7.79%
09/23Applied UV Declares Monthly Preferred Stock Dividend
BU
09/15Applied UV's Airocide® and Lumicide Address CDC's Recommendation for Handling Environments Contaminated by Monkeypox
BU
09/08Applied UV Unit Gets $1.5 Million Order to Provide Furnishings for Florida Resort
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Applied UV to Host Second Quarter 2022 Conference Call on August 16, 2022

08/11/2022 | 04:15pm EDT

Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, August 16, 2022 at 9:00 am ET to review its financial results. Second quarter 2022 financial results will be released after market close on Monday, August 15th and will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI.

Conference Call/Webcast Information

Applied UV's management team will host an investor conference call and live webcast on August 16, 2022, at 9:00 am ET. Investors can access the live webcast via a link on Applied UV's web site or at https://www.webcaster4.com/Webcast/Page/2626/46351. For those planning to participate on the call, please dial +1-888-506-0062 (for domestic calls), or +1-973-528-0011 (for international calls), passcode 660050. A replay of the conference call will be available online on the Applied UV web site, and a dial-in replay will be available for one week following the call at +1-877-481-4010 (for domestic calls) or +1-919-882-2331 (for international calls), replay passcode 46351.

About Applied UV

Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company’s Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices’ proximity. The Company’s patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen’s Airocide® air purification devices are research backed, clinically proven, and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II Medical device, utilizes a proprietary photocatalytic (PCO) bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors and biological gasses into harmless water vapor and green carbon dioxide without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, post-harvest, grocery, cannabis facilities and homes. For more information about Applied UV, Inc., and its subsidiaries, please visit the following website: https://www.applieduvinc.com/.

Forward-Looking Statements

The information contained herein may contain “forward‐looking statements.” Forward-looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward-looking statements are based on the Company’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.


© Business Wire 2022
All news about APPLIED UV, INC.
09/23Applied UV Declares Monthly Preferred Stock Dividend
BU
09/15Applied UV's Airocide® and Lumicide Address CDC's Recommendation for Handling Environme..
BU
09/08Applied UV Unit Gets $1.5 Million Order to Provide Furnishings for Florida Resort
MT
09/08Applied UV Receives $1.5 Million Purchase Order to Provide Premium Furnishings for Luxu..
BU
09/08Applied UV, Inc. Receives $1.5 Million Purchase Order to Provide Premium Furnishings fo..
CI
09/07Applied UV Secures $625,000 Initial Order For Air Purification Systems
MT
09/07Applied UV Advances Efforts in Education Vertical with New $625,000 Order
BU
09/07Applied UV, Inc. Advances Efforts in Education Vertical with New $625,000 Order
CI
08/23Applied UV Declares Monthly Preferred Stock Dividend
BU
08/22APPLIED UV : Amendment to Quarterly Report - Form 10-Q/A
PU
More news
Analyst Recommendations on APPLIED UV, INC.
More recommendations
Financials (USD)
Sales 2022 19,0 M - -
Net income 2022 -9,39 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,95x
Yield 2022 -
Capitalization 18,2 M 18,2 M -
Capi. / Sales 2022 0,96x
Capi. / Sales 2023 0,77x
Nbr of Employees 61
Free-Float 49,6%
Chart APPLIED UV, INC.
Duration : Period :
Applied UV, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APPLIED UV, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 1,42 $
Average target price 6,80 $
Spread / Average Target 379%
EPS Revisions
Managers and Directors
John F. Andrews Chief Executive Officer & Director
Max Munn President & Director
Michael Riccio Chief Financial Officer
John J. Hayman Chief Operating Officer & Senior Vice President
Dallas C. Hack Independent Director
Sector and Competitors
1st jan.Capi. (M$)
APPLIED UV, INC.-47.41%18
KEYENCE CORPORATION-30.92%84 557
SCHNEIDER ELECTRIC SE-33.67%61 746
EATON CORPORATION PLC-22.38%53 428
EMERSON ELECTRIC CO.-20.58%43 662
NIDEC CORPORATION-33.16%36 269